Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?

Affiliations

¹ Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California.
² Division of Transplantation, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
³ Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California.
⁴ Division of Gastroenterology, Department of Medicine, and Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, California.

Comment

Neil Mehta et al. Gastroenterology. 2016 Feb.

. 2016 Feb;150(2):533-4.

doi: 10.1053/j.gastro.2015.08.059. Epub 2015 Dec 21.

¹ Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California.
² Division of Transplantation, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
³ Division of Transplant Surgery, Department of Surgery, University of California San Francisco, San Francisco, California.
⁴ Division of Gastroenterology, Department of Medicine, and Division of Transplant Surgery, Department of Surgery, University of California, San Francisco, San Francisco, California.

No abstract available

Comment in

Reply.
Berry K, Ioannou GN. Berry K, et al. Gastroenterology. 2016 Feb;150(2):535-7. doi: 10.1053/j.gastro.2015.12.030. Epub 2015 Dec 21. Gastroenterology. 2016. PMID: 26718174 No abstract available.

Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
Berry K, Ioannou GN. Berry K, et al. Gastroenterology. 2015 Sep;149(3):669-80; quiz e15-6. doi: 10.1053/j.gastro.2015.05.025. Epub 2015 May 27. Gastroenterology. 2015. PMID: 26021233